Lung Non-Squamous Non-Small Cell Carcinoma Recruiting Phase 3 Trials for Pemetrexed (DB00642)

IndicationStatusPhase
DBCOND0116675 (Lung Non-Squamous Non-Small Cell Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03793179Firstline Pembrolizumab Alone or in Combination With Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients With Stage IV Non-squamous Non-small Cell Lung CancerTreatment